You are here

  • Home
  • Archive
  • Volume 5, Issue 2
  • HIV-associated cardiovascular disease: importance of platelet activation and cardiac fibrosis in the setting of specific antiretroviral therapies

Article metrics

Article menu

Download PDFPDF

Basic and translational research
Review
HIV-associated cardiovascular disease: importance of platelet activation and cardiac fibrosis in the setting of specific antiretroviral therapies

 

Online download statistics by month:

Online download statistics by month: July 2018 to March 2024

AbstractFullPdf
Jul 201811811865
Aug 2018797824
Sep 2018929229
Oct 2018515227
Nov 2018646432
Dec 2018575739
Jan 2019838247
Feb 2019616027
Mar 2019929037
Apr 201910110134
May 2019999744
Jun 2019908938
Jul 2019909029
Aug 2019818127
Sep 2019898929
Oct 201910310339
Nov 2019989937
Dec 2019737232
Jan 2020898936
Feb 2020949432
Mar 2020989835
Apr 2020575629
May 2020525261
Jun 2020474713
Jul 2020464517
Aug 2020464022
Sep 2020434419
Oct 2020423719
Nov 2020464515
Dec 2020585715
Jan 2021454419
Feb 2021393913
Mar 2021626026
Apr 2021454517
May 2021636214
Jun 2021454330
Jul 2021625716
Aug 2021676720
Sep 2021524628
Oct 2021585429
Nov 2021281720
Dec 2021454311
Jan 2022505521
Feb 2022323612
Mar 2022747525
Apr 2022626425
May 2022454423
Jun 2022504321
Jul 2022353318
Aug 202253499
Sep 2022534518
Oct 20221009528
Nov 2022554722
Dec 2022333624
Jan 2023525112
Feb 202395928
Mar 202337367
Apr 2023362811
May 2023434116
Jun 2023313117
Jul 2023353315
Aug 2023383711
Sep 202314614012
Oct 20231201206
Nov 2023595511
Dec 2023696611
Jan 2024959516
Feb 2024949216
Mar 2024676254
Total450943961661